Loading

In silico Study of Curcumin Potentiality for IRE1 Oncoproetin Inactivation: A Hypothesis

Short Communication | Open Access | Volume 2 | Issue 1

  • 1. Department of Botany, Banaras Hindu University, Varanasi-221005, India
+ Show More - Show Less
Corresponding Authors
Akhileshwar Kumar Srivastava, Department of Surgical Oncology, Institute of Medical Sciences, India
ABSTRACT

The accumulated misfolded or unfolded proteins due to cellular stress and oxidative stress induce endoplasmic reticulum stress, which further activates an unfolded protein response (UPR). ER stress is usually maintained at elevated levels in cancer cell in comparison to normal cells with altered metabolism in cancer. Here, we investigated using molecular docking whether curcumin has interactive properties with IRE-1 in cancer cells as a down regulator. The results from molecular docking between curcumin and IRE1 showed that the curcumin could down regulate the human IRE1 oncoprotein expressing in stress condition.

KEYWORDS

•    Curcumin
•    IRE1
•    Molecular docking
•    Stress

CITATION

Srivastava AK, Singh D, Roy BK (2017) In silico Study of Curcumin Potentiality for IRE1 Oncoproetin Inactivation: A Hypothesis. J Bioinform, Genomics, Proteomics 2(1): 1012.

INTRODUCTION

The endoplasmic reticulum is responsible for folding secretory proteins. During homeostasis the folding capacity of the ER and the level of secretory protein synthesis are balanced. Although, if protein synthesis eclipses folding capacity, the level of misfolded protein is sensed and a recovery mechanism is activated, termed the unfolded protein response (UPR). Foremost, UPR signaling reduces protein translation with increasing the ER lumen volume and protein folding capacity, however if homeostasis cannot be restored the UPR signals for the cell to undergo apoptosis [1]. The most evolutionarily conserved UPR pathway is the IRE1- bZIP pathway [2]. The IRE1 resides in the ER membrane, has an N-terminal stress sensing domain in the ER lumen and a cytoplasmic kinase/ribonuclease domain are connected by a single-pass transmembrane helix [3]. The luminal domains dimerise in ER stress taking the cytoplasmic domains together [4]. Further IRE1 undergoes autophosphorylation developing a specific endoribonuclease activity, which hydrolyses 2 stem loops in the pre-mRNA for a bZIP transcription factor [4]. Religation of the RNA causes in a frame shift, and subsequently an active transcription factor is translated, HAC1 in yeast and XBP1 in metazoans [5] that increases transcription of UPR target genes [1]. Recent evidence has explained the UPR activation linking to numerous diseases. The pro-survival IRE1-XBP1 pathway plays a vital role in disease development for inflammatory bowel diseases, metabolic disorders and cancers [6]. The targeting of the IRE1-XBP1 pathway in myeloma and the recent discovery of a key function for this pathway in the progression of aggressive, triple negative breast cancer has revealed that IRE1 has become the focus of several drug discovery programs [7]. A detailed understanding of the IRE1 activation mechanism in humans will accelerate therapeutic development. Therefore present studies focused on a component curcumin as a pleotropic nature is derived from medicinal plant Curcuma longa and are being used against several hazardous diseases. In particular, curcumin, a phenolic compound has been recognized as an antioxidant by scavenging radicals and regulating antioxidant responsive elements and it induces apoptosis via the induction of the cellular stress to the ER in several cancer cells [8]. So, we strived to find interactive potential of curumin with IRE1 to disrupt its natural integrity causing for several diseases including cancer.

EXPERIMENTAL METHODS

Retrieving of 3D structure of compounds

The traditional Indian medicine curcumin (PubChem id: CID_969516) was downloaded in standard data file (SDF) from the database PubChem (www.pubchem.ncbi.nlm.nih. gov) for computational study. The crystal structure of human IRE1 (PDB ID: 5hgi) protein retrieved from protein data bank) has been reported in the literature which possesses different confirmations [9].

Molecular Docking

Docking study of each leading compounds was performed using Patch Dock online server [10]. The number of solutions with their score, area, and six-dimensional transformation space was obtained. These results were used for further refinement and rescoring of 1000 top scoring complexes using Fire Dock [10]. The top ten scoring molecules of each crystal structure were refined automatically by Fire Dock and represented the energy involvement in complex formation as global binding energy, attractive vander Waals, and hydrogen bond energies. Each complex of FireDock was ranked on the basis of minimum global binding energy. Next step, Discovery Studio 4.5 Client [11] for determining the mode of interaction between the receptor and ligands was used.

RESULTS AND DISCUSSION

Present studies explain that the curcumin has interactive properties with IRE1 oncoprotein expressed stress condition (Figure 1).

Visualization of interactive molecules of curcumin with strongest (R1) and lowest complexation to IRE1 (R10).

Figure 1: Visualization of interactive molecules of curcumin with strongest (R1) and lowest complexation to IRE1 (R10).

After flexible molecular docking, we found total 10 best solutions by Fire Dock in which rank1 had strongest complexation (Figure 1) and weakest interaction in rank10 (Figure 1) on the basis of global binding energy. Rank1 represents the binding mode of curcumin with residues (THR584, SER710, GLU651, CYS645, LEU644, ALA597, ALA646, and LEU577) with highest binding energy (-35.94 kcal/mol) and Full Fitness (-4318.09 kcal/mol) (Table 1) whereas binding modes of residues (HIS723, GLU749 and ASP816) in rank10 had lowest binding energy (-7.61 kcal/mol) with Full Fitness (-4306.96 kcal/mol) (Table 1). However, spontaneous interactions of curcumin with IRE1 in both of complexes (R1 and R10) exhibited indicating that curcumin had potential to disrupt the natural integrity of IRE1 of any confirmations [12] also studies explained the curcumin promotes ER stress-mediated apoptosis in cancer through increase of cell type-specific ROS. The present study showed that the curcumin has good interactive properties with IRE1 protein and suggested to be potential inhibitor of IRE1 oncoprotein expressed in stress condition. Hence, curcumin could be approached as therapeutic agents against stress proteins causing for cancer development.

Table 1: Inherent free binding energy (kcal/mol) of curcumin-IRE1 complexes.

Rank Full Fitness (kcal/mol) Estimated G (kcal/mol) Interactive molecules
  1 -4318.09 -35.94 UNK1:O3-THR584, UNK1:O5-SER710:OG
      UNK1:C21-GLU651:OE1, UNK1-CYS645
      UNK1-LEU644, UNK1-ALA597
      UNK1:C21-ALA646:O, UNK1-LEU577
 10 -4306.96 -7.61 UNK1:O4-HIS723:O, UNK1-HIS723
      UNK1-GLU749:OE1, UNK1:O3-ASP816:OD2
REFERENCES

1. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011; 334: 1081-1086.

2. Sidrauski C, Walter P. The transmembrane kinase Ire1p is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response. Cell. 1997; 90: 1031-1039.

3. Cox JS, Shamu CE, Walter P. Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell. 1993; 73: 1197-1206.

4. Shamu CE, Walter P. Oligomerization and phosphorylation of the Ire1p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus. EMBO J. 1996; 15: 3028-3039.

5. Gonzalez TN, Sidrauski C, Dörfler S, Walter P. Mechanism of non-spliceosomal mRNA splicing in the unfolded protein response pathway. EMBO J. 1999; 18: 3119-3132.

6. Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature. 2014; 508: 103-107.

7. Cross BC, Bond PJ, Sadowski PG, Jha BK, Zak J, Goodman JM, et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc Natl Acad Sci U S A. 2012; 109: 869-878. 

8. Ng AP, Chng WJ, Khan M. Curcumin sensitizes acute promyelocytic leukemia cells to unfolded protein response-induced apoptosis by blocking the loss of misfolded N-CoR protein. Mol Cancer Res 2011: 9; 878-888.

9. Feldman CH, Tong M, Wang L, Meza-Acevedo R, Gobillot T, Lebedev I, et al. Structural and Functional Analysis of the Allosteric Inhibition of IRE1 with ATP-Competitive Kinase Ligands. ACS Chem Biol 2016; 11: 2195-2205.

10. Uppalapati SR, Kingston J, Qureshi IA, Murali HS, Batra HV. In silico, in vitro and in vivo analysis of binding affinity between N and C-domains of Clostridium perfringens alpha toxin. PLoS One. 2013; 8: 82024.

11. Usha T, Goyal AK, Lubna S, Prashanth H, Mohan TM, Pande V, et al. Identification of anti-Cancer targets of eco-friendly waste Punica granatum peel by dual reverse virtual screening and binding analysis. Asian Pac J Cancer Prev 2014: 15; 10345-10350.

12. Kim B, Kim HS, Eun-Ji J, Lee Jung YL, Tsang BK, Lim JML et al. Curcumin Induces ER Stress Mediated Apoptosis Through Selective Generation of Reactive Oxygen Species in Cervical Cancer Cells. Molecular Carcinogenesis 2016: 55; 918-928.

Srivastava AK, Singh D, Roy BK (2017) In silico Study of Curcumin Potentiality for IRE1 Oncoproetin Inactivation: A Hypothesis. J Bioinform, Genomics, Proteomics 2(1): 1012

Received : 30 Jan 2017
Accepted : 17 Feb 2017
Published : 20 Feb 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X